The following companies’ shares may be active in Zurich. Stock symbols are in parentheses after company names. Prices are from the last close.
Cosmo Pharmaceuticals SpA (COPN SW): The Italian developer of treatments for digestive-tract infections said first-half revenue rose to 14.3 million euros ($18.7 million) while operating profit advanced to 2.1 million euros. The shares were unchanged at 16 Swiss francs.
EFG International AG (EFGN SW): The Swiss bank had its long-term issuer rating lowered to A3 from A2 by Moody’s Investors Service. The shares tumbled 6.8 percent to 11.7 francs.
Sika AG (SIK SW): Europe’s biggest maker of chemicals used in construction said first-half net income rose 63 percent to 150.5 million francs ($144.5 million). The shares rose 2 percent to 1,963 francs.
Swissquote Group Holding AG (SQN SW): Switzerland’s largest online broker said first-half net profit fell to 13.7 million francs from 15.9 million francs a year earlier because of higher costs. The company said it’s sticking to its full-year growth targets. The shares rose 0.5 percent to 44 francs.